A feedback system lets the body know when no more glucagon is needed. When everything works correctly, the body will produce insulin to move glucose out of the blood and into the cells to ...

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor ... Genetic risk scores for predicting insulin resistance that were developed for adults are also tied to ...

Research shows short-term fasting improves glucose regulation, while long-term fasting in young mice impairs β cell function, ...

and insulin—that are highly homologous in structure and function. The IGFs can bind to six well-characterized soluble IGF-binding proteins (IGFBPs) as well as to two transmembrane tyrosine ...

Sliding scale insulin therapy involves following a chart of insulin dosages. A doctor will help a person with diabetes create this chart based on factors like how their body responds to insulin ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...